Диссертация (1154706), страница 14
Текст из файла (страница 14)
Keller M., Pignier C., Niggli E. Mechanisms of Na+-Ca2+ exchange inhibition byamphiphiles in cardiac myocytes: importance of transbilayer movement. // J MembrBiol. - 2004. - № 198. - C. 159–175.91. Keller H., Bezjak V., Stegaru B., Buss J. Ventricular function in cirrhosis andportosystemic shunt: a two-dimensional echocardiographic study // Hepatology. 1988. - № 8. - C. 658–662.92. Kempler, P., Varadi, A., Kadar, E., Szalay F.
Autonomic and peripheralneuropathy in primary biliary cirrhosis: evidence of small sensory fibre damage andprolongation of the QT interval. // Hepatology. - 1994.- № 21. - C. 1150–1151.93. Kia L. Role of Pretransplant Echocardiographic Evaluation in PredictingOutcomes Following Liver Transplantation // American Journal of Transplantation.
2013. - № 9 (13). - C. 2395–2401.94. Kisch B. Electron microscopy of the atrium of the heart. I.Guinea pig. // Exp MedSurg. - 1956. - № 14.- C. 99–112.95. Klatsky A.L. Alcohol and hypertension. - 2006. - C. 108–17.96. Klatsky A.L. Alcohol and cardiovascular diseases: where do we stand today? //Journal of Internal Medicine.- 2015. - № 3 (278).- C. 1365–2796.97. Kodavali L. Alcohol and its relationship to blood pressure. // Curr HypertensRep.- 2006. - № 8. - C. 338–44.10598. Kovacs, A., Schepke, M., Heller, J., Schild, H.H., Flacke S.
Short-term effects oftransjugular intrahepatic shunt on cardiac function assessed by cardiac MRI:Preliminary results. // CardiovascInterventRadiol.- 2010. - № 33. - C. 290–296.99. Kowalski H.J. The cardiac output at rest in Laennec’s cirrhosis. // J Clin Invest. 1953. - (32). - C. 1025–1033.100. Krag A., Bendtsen, F., Henriksen, J.H., Møller S. Low cardiac output predictsdevelopment of hepatorenal syndrome and survival in patients with cirrhosis andascites // Gut.
- 2010. - № 59.- C. 105–110.101. Krowka M. Pulmonary Hemodynamics and Perioperative CardiopulmonaryRelated Mortality in Patients With Portopulmonary Hypertension Undergoing LiverTransplantation // Liver Transplantation. - 2000. - № 4 (6). - C. 443–450.102. Krowka M.J. Hepatopulmonary syndrome. Clinical observations and lack oftherapeutic response to somatostatin analogue. // CHEST Journal.
- 1993. - № 2(104). - C. 515.103. Krowka M.J. Portopulmonary hypertension: Results from a 10-year screeningalgorithm // Hepatology. - 2006. - № 6 (44). - C. 1502–1510.104. Krowka M.J., Edwards W.D. A spectrum of pulmonary vascular pathology inportopulmonary hypertension // Liver Transplantation.- 2000. - № 2 (6).- C. 241–242.105. Lazzeri, C., Lavilla, G., Laffi, G., Vecchiarino, S., Gambilonghi, F., Gentilini P.Autonomic regulation of heart rate and QT interval in nonalcoholic cirrhosis withascites. // Digestion.
- 1997. - № 58. - C. 580–586.106. Lebrec D., Giuily N., Hadenque A., Vilgrain V., Moreau P. Transjugularintrahepatic portosystemic shunt: comparison with paracentesis in patients withcirrhosis and refractory ascites: a randomized trial. // Hepatology. - 1996. - (25).- C.135–144.107. Lebrec D. Management of refractory ascites by the transjugular intrahepaticportosystemic shunt (TIPS).
// Gastroenterol Clin Biol.- 2008. - № 32.- C. 717–720.108. Lee S.S. Cardiac abnormalities in liver cirrhosis. // WestJMed. - 1989.- № 151.106- C. 530–535.109. Lee S.S., Hadengue A., Moreau R., Sayegh R., Hillon P. Postprandialhemodynamic responses in patients with cirrhosis. // Hepatology. - 1988.- (8). - C.647–651.110.
Lewis F.W., Adair O.R. Arterial vasodilation is not the cause of increasedcardiac output in cirrhosis. // Gastroenterology. - 1992.- № 102. - C. 1024–1029.111. Licata A. NT- pro BNP Plasma Level and Atrial Volume Are Linked to theSeverity of Liver Cirrhosis // PLoS ONE.- 2013.- № 8 (8). - C. 68364.112.
Limas C.J., Guiha N.H., Lekagul O.C. Impaired left ventricular function inalcoholic cirrhosis with ascites. Ineffectiveness of ouabain. // Circulation.- 1974.(49). - C. 754–760.113. Liu H, Song D. Role of heme oxygenase-carbon monoxide pathway inpathogenesis of cirrhotic cardiomyopathy in the rat // Am J Physiol Gastrointest LiverPhysiol.
- 2001.- № 280.- C. 68–74.114. Liu H. Nuclear factor-kappaB inhibition improves myocardial contractility inrats with cirrhotic cardiomyopathy // Liver Int. - 2008. - № 28. - C. 640–648.115. Loyke H.F. The relationship of cirrhosis of the liver to hypertension: a study of504 cases of cirrhosis of the liver. // Am J Med Sci. - 1955.- № 230. - C. 627–632.116. Lunseth J. H., Olmstead E.G., Forks G. A. A study of heart disease in onehundred eight hospitalized patients dying with portal cirrhosis. // Arc Int Med. - 1958.- № 102. - C.
405–413.117. Lunzer M.R, Newman S.P., Bernard A.G., Manghani K.K., Sherlock S.P.Impaired cardiovascular responsiveness in liver disease. // Lancet.- 1975.- № 238285.118. Marmot M. Commentary: Reflections on alcohol and coronary heart disease. //International Journal of Epidemiology.- 2001.- (30). - C. 729–734.119. Ma Z., Lee S.S. Effects of altered cardiac membrane fluidity on beta-adrenergicreceptor signalling in rats with cirrhotic cardiomyopathy. // Hepatology.
- 1997. - №26.- C. 904–912.107120. Ma Z., Meddings J.B. Membrane physical properties determine cardiac betaadrenergic receptor function in cirrhotic rats. // Am J Physiol. - 1994. - № 267.- C.87–93.121. Ma Z., Miyamoto A. Role of altered β-adrenergic receptor signal transductionin the pathogenesis of cirrhotic cardiomyopathy in rats.
// Gastroenterology.- 1996. № 110.- C. 1191–1198.122. Ma, Z. Lee S.S. Cirrhotic cardiomyopathy: getting to the heart of the matter //Hepatology. - 1996.- № 24. - C. 451–459.123. Marchi K.C, Muniz J.J. Hypertension and chronic ethanol consumption: what dowe know after a century of study? // WorldJCardiol.- 2014.
- № 6.- C. 283–94.124. Mart nez G. Hepatopulmonary syndrome in candidates for liver transplantation// Journal of Hepatology.- 2001. - № 5 (34). - C. 651–657.125. Marwick T.H. Measurement of Strain and Strain Rate by Echocardiography //Journal of the American College of Cardiology. - 2006. - № 7 (47). - C. 1313–1327.126. McDonnell P.J., Toye P.A., Hutchins G.M. Primary Pulmonary Hypertensionand Cirrhosis: Are They Related? // American Review of Respiratory Disease.
1983.- № 4 (127). - C. 437–441.127. Merli M. Cardiac dysfunction in cirrhosis is not associated with the severity ofliver disease // European Journal of Internal Medicine. - 2013. - № 2 (24). - C. 172–176.128. Metsanen H. Arrythmias and alcohol abuse in working-aged men. // Pharmacol.And Toxicol. - 1990. - № 1 (67). - C. 2.129. Mohamed, R., Forsey, P.R., Davies, M.K., Neuberger J.M. Effect of livertransplantation on QT interval prolongation and autonomic dysfunction in end-stageliver disease // Hepatology.
- 1996. - № 23. - C. 1128–1134.130. Møller S., Iversen J.S., Henriksen J.H. Reduced baroreflex sensitivity inalcoholic cirrhosis: relations to hemodynamics and humoral systems. // Am J PhysiolHeart Circ Physiol.- 2007. - № 292. - C. 2966–2972.131. Moller S, Sondergaard L, Mogelvang J, Henriksen O. Decreased right heart108blood volume determined by magnetic resonance imaging: evidence of centralunderfilling in cirrhosis.
// Hepatology. - 1995. - № 22. - C. 472–478.132. Møller S. Cirrhotic cardiomyopathy // Hepatology. - 2010. - № 53. - C. 179–190.133. Møller, S. and Henriksen J.H. Cardiovascular dysfunction in cirrhosis.Pathophysiological evidence of a cirrhotic cardiomyopathy // Scand J Gastroenterol. 2001.- № 36. - C. 785–794.134. Møller, S. and Henriksen J.H. Cardiovascular complications of cirrhosis // Gut.2008. - № 57.
- C. 268–278.135. Moreau R. Endogenous factors involved in the control of arterial tone incirrhosis. // Hepatology.- 1995. - № 22. - C. 370–376.136. Murray J.F., Dawson A.M. Circulatory changes in chronic liver disease. //AmJMed.- 1958.- № 24. - C. 358–367.137. Murray K.F., Carithers R.L. AASLD practice guidelines: Evaluation of thepatient for liver transplantation // Hepatology. - 2005.
- № 6 (41). - C. 1407–1432.138. Nazar, A., Sitges, M., Guevara, M., Terra, C., Marinelli, A., Villa F.Cardiomyopathy in patients with cirrhosis. Frequency, characteristics andrelationship with circulatory dysfunction and prognosis. // Journal of Hepatology.2009. - № 50.- C. 85.139. Nazar A. LEFT ventricular function assessed by echocardiography in cirrhosis:Relationship to systemic hemodynamics and renal dysfunction // Journal ofHepatology- 2013. - № 1 (58).
- C. 51–57.140. Neuhofer W., Gulberg V., Gerbes A.L. Endothelin and endothelin receptorantagonism in portopulmonary hypertension // European Journal of ClinicalInvestigation. - 2006.- № 3 (36). - C. 54–61.141. Obbergh L., Vallieres Y.. Cardiac modifications occurring in the ascitic rat withbiliary cirrhosis are nitric oxide related // Hepatology. - 1996.- № 24.- C. 747–752.142. Ortiz-Olvera N.X., Castellanos-Pallares G., Gоmez-Jimоnez L.M. Anatomicalcardiac alterations in liver cirrhosis: an autopsy study.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
